Fred M. Eckel, RPh, MS, Pharmacy Times Editor-in-Chief
Recently, I attended the Generic Pharmaceutical
Association (GPhA) annual meeting. The image of
generic pharmaceuticals has really changed. It was
not that long ago that generic drug manufacturers
and the products they made were criticized by many. The
image of the generic drug product was that of a poor imitation
of the branded product that you took at some risk. That
is not true today. In February, Novartis AG, the Swiss pharmaceutical
company, announced that it was buying 2 generic
drug companies for $8.4 billion. No one would make this
kind of investment in generic drug products without some
assurance that these products are well accepted, are an important
part of the entire drug market, and have a bright
future. Novartis AG must think generic drugs have arrived.
At the GPhA conference, I heard the administrator of the
Centers for Medicare and Medicaid Services, Dr. Mark
McClellan, former FDA commissioner, state that "generic
drugs are just as safe but cost less, and we absolutely need
their increased use."He was speaking about the new
Medicare Part D program becoming operational in 2006, but
such an endorsement suggests that he thinks generic drugs
have arrived.
Also speaking at the GPhA conference was Bill Novelli,
chief executive officer of AARP. In his talk, he discussed the
importance of generic drugs and stated that his organization
would be continuing its campaign to alert seniors that
generic drugs are safe and can save them money. AARP must
believe that generic drugs have arrived.
Finally, in conversations with many community pharmacists,
I hear that generic drugs are important to their bottom
line. Some have even suggested that they are still in business
because generic drug usage has increased to over 50% of all
prescriptions filled. They talk about a quality product that
allows them to cover more of their costs. These individuals
would say that generic drugs have arrived. With the number
of drugs losing patent protection in the next few years, we
will see more new generic products, and the use of generic
drugs as a percentage of drugs dispensed may increase to over
60%. By then, everyone will probably agree that generic
drugs have arrived, if they don't believe it now.